Anuh Pharma ends marginally higher; WHO suspends drug

The scrip opened at Rs. 176.3 and has touched a high and low of Rs. 179.7 and Rs. 159 respectively.

Apr 21, 2016 04:04 IST India Infoline News Service

Anuh Pharma Ltd ended 0.40% higher at Rs. 176.60 on BSE. The company said in a BSE filing that in view of the EDQM suspension, the WHO PQ authorities have suspended Pyrazinamide and Sulfadoxine from the WHO list of prequalified API’s until the WHO led inspection.

The scrip opened at Rs. 176.3 and has touched a high and low of Rs. 179.7 and Rs. 159 respectively. So far 134283(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 440.74 crore.

The BSE group 'XC' stock of face value Rs. 5 has touched a 52 week high of Rs. 414.75 on 12-Aug-2015 and a 52 week low of Rs. 174.1 on 20-Apr-2016. Last one week high and low of the scrip stood at Rs. 179.5 and Rs. 174.1 respectively.

The promoters holding in the company stood at 70.98 % while Institutions and Non-Institutions held 0 % and 29.02 % respectively.

The stock is currently trading below its 200 DMA.

Related Story

Open Free Demat Account (Rs699)